IDSA GUIDELINES Bundle (free trial)

Chronic Kidney Disease in HIV-Infected Patients

IDSA GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/418521

Contents of this Issue

Navigation

Page 14 of 15

Table 5. Strength of Recommendation and Quality of Evidence Category/Grade Definition Recommendation S - Strong Clear desirable or undesirable effects W - Weak Desirable and undesirable effects closely balanced or uncertain Quality of Evidence H - High Consistent evidence from well-performed RCTs or exceptionally strong evidence from unbiased observational studies M - Moderate Evidence from RCTs with important limitations or exceptionally strong evidence from unbiased observational studies L - Low Evidence for at least one critical outcome from observational studies, RCTs with serious flaws, or indirect evidence VL - Very low Evidence for at least one critical outcome from unsystematic clinical observations or very indirect evidence GRADE Implication Comment S-H Applies to most patients in most circumstances Further research is unlikely to change estimate S-M Further research may change estimate S-L S-VL Estimate of effect for at least one critical outcome is very uncertain W-H e best action may differ depending on circumstances or patients or societal values Further research is unlikely to change estimate W-M Alternative approaches likely to be better for some patients under some circumstances Further research may change estimate W-L Other alternatives may be equally reasonable W-VL Any estimate of effect, for at least one critical outcome, is very uncertain For the complete GRADE Strength of Recommendations and Quality of the Evidence Table, visit the IDSA website: http://www.idsociety.org/Guidelines_Other/ 13

Articles in this issue

Links on this page

Archives of this issue

view archives of IDSA GUIDELINES Bundle (free trial) - Chronic Kidney Disease in HIV-Infected Patients